Precision Medicine Group Launches Institute@Precision, a Collaborative Forum for Biopharma Innovation
Expert community unites leaders from early clinical development through global commercialization to discuss most pressing topics in biopharma and help innovators bring novel treatments to life
BETHESDA, MD., November 3, 2025 — Precision Medicine Group (Precision), a leading provider of next-generation drug development, CRO and commercialization services, today announced the launch of Institute@Precision, an expert community forum where Precision’s scientists, physicians, regulators, commercial leaders, clients, and global experts convene to address the most pressing challenges in biopharma. Each quarter, Precision will engage global thought leaders on focused topics impacting the industry, offering actionable insights that help innovators anticipate change, adapt strategy and accelerate scientific breakthroughs. (more…)
Precision Medicine Group Announces Appointment of Tracey Leahy as Chief People Officer
BETHESDA, MD., September 16, 2025 — Precision Medicine Group (Precision), a leading provider of next-generation drug development, CRO and commercialization services, today announced the appointment of Tracey Leahy as the company’s Chief People Officer (CPO), effective immediately. Ms. Leahy will be aligning workforce strategies with business goals and is responsible for all aspects of Precision’s Human Resources (HR) function, including talent acquisition and management, total rewards, learning and development, and HR operations. (more…)
Eric Hodgins joins Precision Medicine Group as CITO
Precision Medicine Group Names Pharma Services Innovator, Eric Hodgins, as Chief Information and Technology Officer
Industry veteran with a 30-year track record in building award-winning clinical and commercial technologies, Hodgins will focus on developing and enriching transformative technologies across Precision’s R&D and commercial services
BETHESDA, Md., April 16, 2025 – Precision Medicine Group (Precision), a leading provider of next-generation drug development, CRO and commercialization services, today announced the appointment of Eric Hodgins as the company’s Chief Information and Technology Officer, overseeing all of the company’s technology assets. (more…)
Pharma’s ‘Best-Kept Secret’
Our CEO, Margaret Keegan, is featured in the December issue of Pharmaceutical Executive candidly discussing the future of clinical development, the changing commercialization sector and the manufacturing of tomorrow’s medicines.
(more…)
Precision Medicine Group Announces Key Leadership Appointments
Karl Deonanan appointed Chief Financial Officer
Matt DeZee named to newly established role, Chief Transformation and Strategy Officer
Bethesda, Md., October 23, 2024—Precision Medicine Group (Precision), a leading next-generation provider of drug development and commercialization services, today announced key leadership changes to support its next phase of growth. This includes the appointment of Karl Deonanan as Chief Financial Officer (CFO). Mr. Deonanan succeeds Matt DeZee, who has served as CFO of Precision since 2020 and will be transitioning to the newly created role of Chief Transformation and Strategy Officer (CTSO), effective immediately.